Literature DB >> 15238490

Clostridium difficile infection in hospitals: a brewing storm.

Louis Valiquette, Donald E Low, Jacques Pépin, Allison McGeer.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15238490      PMCID： PMC437677          DOI： 10.1503/cmaj.1040957

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  14 in total

Review 1.  SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Authors:  Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2003-05       Impact factor: 3.254

2.  Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001.

Authors:  Lennox K Archibald; Shailen N Banerjee; William R Jarvis
Journal:  J Infect Dis       Date:  2004-04-20       Impact factor: 5.226

3.  Hospitals battling outbreaks of C. difficile.

Authors:  Laura Eggertson; Barbara Sibbald
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

4.  Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.

Authors:  Ramsey M Dallal; Brian G Harbrecht; Arthur J Boujoukas; Carl A Sirio; Linda M Farkas; Kenneth K Lee; Richard L Simmons
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

5.  A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group.

Authors:  O Karlström; B Fryklund; K Tullus; L G Burman
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

6.  Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.

Authors:  Lorraine Kyne; Mary Beth Hamel; Rajashekhar Polavaram; Ciarán P Kelly
Journal:  Clin Infect Dis       Date:  2001-12-17       Impact factor: 9.079

7.  Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years.

Authors:  Philip Carling; Teresa Fung; Ann Killion; Norma Terrin; Michael Barza
Journal:  Infect Control Hosp Epidemiol       Date:  2003-09       Impact factor: 3.254

8.  Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables.

Authors:  S E Brooks; R O Veal; M Kramer; L Dore; N Schupf; M Adachi
Journal:  Infect Control Hosp Epidemiol       Date:  1992-02       Impact factor: 3.254

9.  Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Authors:  Sandra Dial; Khalid Alrasadi; Chantal Manoukian; Allen Huang; Dick Menzies
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

10.  Clostridium difficile colitis: an increasingly aggressive iatrogenic disease?

Authors:  Arden M Morris; Blair A Jobe; Mark Stoney; Brett C Sheppard; Clifford W Deveney; Karen E Deveney
Journal:  Arch Surg       Date:  2002-10
View more
  15 in total

1.  First, the bad news...

Authors: 
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

2.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

3.  Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial.

Authors:  M Beausoleil; N Fortier; S Guénette; A L'ecuyer; M Savoie; M Franco; J Lachaine; K Weiss
Journal:  Can J Gastroenterol       Date:  2007-11       Impact factor: 3.522

4.  Key research issues in Clostridium difficile.

Authors:  George Zhanel; Greg Hammond
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

5.  Analysis of proline reduction in the nosocomial pathogen Clostridium difficile.

Authors:  Sarah Jackson; Mary Calos; Andrew Myers; William T Self
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

6.  Do admissions and discharges to long-term care facilities influence hospital burden of Clostridium difficile infection?

Authors:  R Ricciardi; J Nelson; J L Griffith; T W Concannon
Journal:  J Hosp Infect       Date:  2011-12-01       Impact factor: 3.926

7.  A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial.

Authors:  Jennifer Peppe; Andrew Porzio; David M Davidson
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

8.  Distinctive profiles of infection and pathology in hamsters infected with Clostridium difficile strains 630 and B1.

Authors:  David Goulding; Harold Thompson; Jenny Emerson; Neil F Fairweather; Gordon Dougan; Gill R Douce
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

9.  Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.

Authors:  Mini Kamboj; Kun Xiao; Anna Kaltsas; Yao-Ting Huang; Janet Sun; Dick Chung; Saliangi Wu; Anna Sheahan; Kent Sepkowitz; Ann A Jakubowski; Genovefa Papanicolaou
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-25       Impact factor: 5.742

10.  Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile.

Authors:  Paul L Hinkson; Carol Dinardo; Daniel DeCiero; Jeffrey D Klinger; Robert H Barker
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.